Drewnowski A, Rehm CD, Constant F. Water and beverage consumption among adults in the United States: cross-sectional study using data from NHANES 2005–2010. BMC Public Health. 2013;13:1068.
Ludwig IA, Clifford MN, Lean MEJ, Ashihara H, Crozier A. Coffee: biochemistry and potential impact on health. Food Funct. 2014;5:1695–717.
Sang SM, Lambert JD, Ho CT, Yang CS. The chemistry and biotransformation of tea constituents. Pharmacol Res. 2011;64:87–99.
Noordzij M, Uiterwaal CSPM, Arends L, Kok F, Grobbee D, Geleijnse JM. Blood pressure response to chronic intake of coffee and caffeine: a meta-analysis of randomized controlled trials. J Hypertens. 2005;23:921–8.
Cornelis MC, El-Sohemy A. Coffee, caffeine, and coronary heart disease. Curr Opin Clin Nutr Metab Care. 2007;10:745–51.
van Dam RM, Willett WC, Manson JE, Hu FB. Coffee, caffeine, and risk of type 2 diabetes––a prospective cohort study in younger and middle-aged US women. Diabetes Care. 2006;29:398–403.
Zhang R, Wang Y, Song B, Jørgensen HS, Xu Y. Coffee consumption and risk of stroke: a meta-analysis of cohort studies. Cent Eur J Med. 2012;7:310–6.
Butt MS, Sultan MT. Coffee and its consumption: benefits and risks. Crit Rev Food Sci Nutr. 2011;51:363–73.
Aleksandrova K, Bamia C, Drogan D, Lagiou P, Trichopoulou A, Jenab M, Fedirko V, et al. The association of coffee intake with liver cancer risk is mediated by biomarkers of inflammation and hepatocellular injury: data from the European Prospective Investigation into Cancer and Nutrition. Am J Clin Nutr. 2015;102:1498–508.
Guertin KA, Loftfield E, Boca SM, Sampson JN, Moore SC, Xiao Q, Huang W-Y, et al. Serum biomarkers of habitual coffee consumption may provide insight into the mechanism underlying the association between coffee consumption and colorectal cancer. Am J Clin Nutr. 2015;101:1000–11.
Yang CS, Hong J. Prevention of chronic diseases by tea: possible mechanisms and human relevance. Annu Rev Nutr. 2013;33:161–81.
Yang W-S, Wang W-Y, Fan W-Y, Deng Q, Wang X. Tea consumption and risk of type 2 diabetes: a dose-response meta-analysis of cohort studies. Br J Nutr. 2014;111:1329–39.
Onakpoya I, Spencer E, Heneghan C, Thompson M. The effect of green tea on blood pressure and lipid profile: a systematic review and meta-analysis of randomized clinical trials. Nutr Metab Cardiovasc Dis. 2014;24:823–36.
Yuan J-M, Sun C, Butler LM. Tea and cancer prevention: epidemiological studies. Pharmacol Res. 2011;64:123–35.
Hu FB, Malik VS. Sugar-sweetened beverages and risk of obesity and type 2 diabetes: epidemiologic evidence. Physiol Behav. 2010;100:47–54.
Nettleton JA, Lutsey PL, Wang Y, Lima JA, Michos ED, Jacobs DR Jr. Diet soda intake and risk of incident metabolic syndrome and type 2 diabetes in the Multi-Ethnic Study of Atherosclerosis (MESA). Diabetes Care. 2009;32:688–94.
Lin J, Curhan GC. Associations of sugar and artificially sweetened soda with albuminuria and kidney function decline in women. Clin J Am Soc Nephrol. 2011;6:160–6.
Arab L, Il'yasova D. “The epidemiology of tea consumption and colorectal cancer incidence.” J Nutr. 2003;133(10):3310s–3318s.
Rosner B, Willett WC, Spiegelman D. Correction of logistic regression relative risk estimates and confidence intervals for systematic within-person measurement error. Stat Med. 1989;8:1051–69. discussion 71–3
Potischman N, Freudenheim JL. Biomarkers of nutritional exposure and nutritional status: an overview. J Nutr. 2003;133:873S–4S.
Jenab M, Slimani N, Bictash M, Ferrari P, Bingham SA. Biomarkers in nutritional epidemiology: applications, needs and new horizons. Hum Genet. 2009;125:507–25.
Gao Q, Practico G, Scalbert A, Vergeres G, Kolehmainen M, Manach C, Brennan L, et al. A scheme for a flexible classification of dietary and health biomarkers. Genes Nutr. 2017;12:34.
Practico G, Gao Q, Scalbert A, Vergeres G, Kolehmainen M, Manach C, Brennan L, et al. Guidelines for Food Intake Biomarker Reviews (FIBRev): how to conduct an extensive literature search for food intake biomarker discovery. Genes Nutr. 2017; in press
Moher D, Liberati A, Tetzlaff J, Altman DG, Grp P. Preferred Reporting Items for Systematic Reviews and Meta-Analyses: the PRISMA statement. PLoS Med. 2009;6:e1000097.
Rechner AR, Spencer JP, Kuhnle G, Hahn U, Rice-Evans CA. Novel biomarkers of the metabolism of caffeic acid derivatives in vivo. Free Radic Biol Med. 2001;30:1213–22.
Ito H, Gonthier M-P, Manach C, Morand C, Mennen L, Rémésy C, Scalbert A. Polyphenol levels in human urine after intake of six different polyphenol-rich beverages. Br J Nutr. 2005;94:500–9.
Stalmach A, Mullen W, Barron D, Uchida K, Yokota T, Cavin C, Steiling H, et al. Metabolite profiling of Hydroxycinnamate derivatives in plasma and urine after the ingestion of coffee by humans: identification of biomarkers of coffee consumption. Drug Metab Dispos. 2009;37:1749–58.
Stalmach A, Williamson G, Crozier A. Impact of dose on the bioavailability of coffee chlorogenic acids in humans. Food Funct. 2014;5:1727–37.
Lang R, Dieminger N, Beusch A, Lee YM, Dunkel A, Suess B, Skurk T, et al. Bioappearance and pharmacokinetics of bioactives upon coffee consumption. Anal Bioanal Chem. 2013;405:8487–503.
Heinzmann SS, Holmes E, Kochhar S, Nicholson JK, Schmitt-Kopplin P. 2-Furoylglycine as a candidate biomarker of coffee consumption. J Agric Food Chem. 2015;63:8615–21.
Clifford MN. Chlorogenic acids and other cinnamates––nature, occurence and dietary burden. J Sci Food Agric. 1999;79:362–72.
Hodgson JM, Chan SY, Puddey IB, Devine A, Wattanapenpaiboon N, Wahlqvist ML, Lukito W, et al. Phenolic acid metabolites as biomarkers for tea- and coffee-derived polyphenol exposure in human subjects. Br J Nutr. 2004;91:301–6.
Mennen L, Sapinho D, Ito H, Galan P, Hercberg S, Scalbert A. Urinary flavonoids and phenolic acids as biomarkers of intake for polyphenol-rich foods. Br J Nutr. 2006;96:191–8.
Zamora-Ros R, Achaintre D, Rothwell JA, Rinaldi S, Assi N, Ferrari P, Leitzmann M, et al. Urinary excretions of 34 dietary polyphenols and their associations with lifestyle factors in the EPIC cohort study. Sci Rep. 2016;6:26905.
Lang R, Wahl A, Stark T, Hofmann T. Urinary N-methylpyridinium and trigonelline as candidate dietary biomarkers of coffee consumption. Mol Nutr Food Res. 2011;55:1613–23.
Lloyd AJ, Beckmann M, Haldar S, Seal C, Brandt K, Draper J. Data-driven strategy for the discovery of potential urinary biomarkers of habitual dietary exposure. Am J Clin Nutr. 2013;97:377–89.
Edmands WM, Ferrari P, Rothwell JA, Rinaldi S, Slimani N, Barupal DK, Biessy C, et al. Polyphenol metabolome in human urine and its association with intake of polyphenol-rich foods across European countries. Am J Clin Nutr. 2015;102:905–13.
Rothwell JA, Fillâtre Y, Martin J-F, Lyan B, Pujos-Guillot E, Fezeu L, Hercberg S, et al. New biomarkers of coffee consumption identified by the non-targeted Metabolomic profiling of cohort study subjects. PLoS One. 2014;9:e93474.
Guertin KA, Moore SC, Sampson JN, Huang W-Y, Xiao Q, Stolzenberg-Solomon RZ, Sinha R, et al. Metabolomics in nutritional epidemiology: identifying metabolites associated with diet and quantifying their potential to uncover diet-disease relations in populations. Am J Clin Nutr. 2014;100:208–17.
Kuwayama K, Tsujikawa K, Miyaguchi H, Kanamori T, Iwata YT, Inoue H. Time-course measurements of caffeine and its metabolites extracted from fingertips after coffee intake: a preliminary study for the detection of drugs from fingerprints. Anal Bioanal Chem. 2013;405:3945–52.
Berchtold C, Meier L, Steinhoff R, Zenobi R. A new strategy based on real-time secondary electrospray ionization and high-resolution mass spectrometry to discriminate endogenous and exogenous compounds in exhaled breath. Metabolomics. 2013;10:291–301.
Stalmach A, Troufflard S, Serafini M, Crozier A. Absorption, metabolism and excretion of Choladi green tea flavan-3-ols by humans. Mol Nutr Food Res. 2009;53 Suppl 1:S44–53.
Calani L, Del Rio D, Luisa Callegari M, Morelli L, Brighenti F. Updated bioavailability and 48 h excretion profile of flavan-3-ols from green tea in humans. Int J Food Sci Nutr. 2012;63:513–21.
Nakagawa K, Okuda S, Miyazawa T. Dose-dependent incorporation of tea catechins, (−)-epigallocatechin-3-gallate and (−)-epigallocatechin, into human plasma. Biosci Biotechnol Biochem. 1997;61:1981–5.
August DA, Landau J, Caputo D, Hong J, Lee MJ, Yang CS. Ingestion of green tea rapidly decreases prostaglandin E2 levels in rectal mucosa in humans. Cancer Epidemiol Biomark Prev. 1999;8:709–13.
Kimura M, Umegaki K, Kasuya Y, Sugisawa A, Higuchi M. The relation between single/double or repeated tea catechin ingestions and plasma antioxidant activity in humans. Eur J Clin Nutr. 2002;56:1186–93.
Luo H, Cox SB, Gao W, Yu J, Tang L, Wang J-S. Metabolic profiling in validation of plasma biomarkers for green tea polyphenols. Metabolomics. 2006;2:235–41.
Wu AH, Spicer D, Stanczyk FZ, Tseng C-C, Yang CS, Pike MC. Effect of 2-month controlled green tea intervention on lipoprotein cholesterol, glucose, and hormone levels in healthy postmenopausal women. Cancer Prev Res (Phila). 2012;5:393–402.
van het Hof KH, Wiseman SA, Yang CS, Tijburg LB. Plasma and lipoprotein levels of tea catechins following repeated tea consumption. Proc Soc Exp Biol Med. 1999;220:203–9.
Renouf M, Marmet C, Guy PA, Beaumont M, Lepage M, Williamson G, Dionisi F. Dose-response plasma appearance of green tea catechins in adults. Mol Nutr Food Res. 2013;57:833–9.
Daykin CA, Van Duynhoven JP, Groenewegen A, Dachtler M, Van Amelsvoort JM, Mulder TP. Nuclear magnetic resonance spectroscopic based studies of the metabolism of black tea polyphenols in humans. J Agric Food Chem. 2005;53:1428–34.
Van Dorsten FA, Daykin CA, Mulder TPJ, Van Duynhoven JPM. Metabonomics approach to determine metabolic differences between green tea and black tea consumption. J Agric Food Chem. 2006;54:6929–38.
van Velzen EJ, Westerhuis JA, van Duynhoven JP, van Dorsten FA, Grun CH, Jacobs DM, Duchateau GS, et al. Phenotyping tea consumers by nutrikinetic analysis of polyphenolic end-metabolites. J Proteome Res. 2009;8:3317–30.
van Duynhoven J, van der Hooft JJJ, van Dorsten FA, Peters S, Foltz M, Gomez-Roldan V, Vervoort J, et al. Rapid and sustained systemic circulation of conjugated gut microbial catabolites after single-dose black tea extract consumption. J Proteome Res. 2014;13:2668–78.
Shahrzad S, Aoyagi K, Winter A, Koyama A, Bitsch I. Pharmacokinetics of gallic acid and its relative bioavailability from tea in healthy humans. J Nutr. 2001;131:1207–10.
van Velzen EJJ, Westerhuis JA, Grun CH, Jacobs DM, Eilers PHC, Mulder TP, Foltz M, et al. Population-based nutrikinetic modeling of polyphenol exposure. Metabolomics. 2014;10:1059–73.
van der Pijl PC, Foltz M, Glube ND, Peters S, Duchateau GSMJE. Pharmacokinetics of black tea-derived phenolic acids in plasma. J Funct Foods. 2015;17:667–75.
Hodgson JM, Morton LW, Puddey IB, Beilin LJ, Croft KD. Gallic acid metabolites are markers of black tea intake in humans. J Agric Food Chem. 2000;48:2276–80.
Neveu V, Perez-Jiménez J, Vos F, Crespy V, du Chaffaut L, Mennen L, Knox C, et al. Phenol-explorer: an online comprehensive database on polyphenol contents in foods. Database. 2010;2010:bap024.
Hakim IA, Harris RB, Brown S, Chow HH, Wiseman S, Agarwal S, Talbot W. Effect of increased tea consumption on oxidative DNA damage among smokers: a randomized controlled study. J Nutr. 2003;133:3303s–9s.
Henning SM, Niu Y, Lee NH, Thames GD, Minutti RR, Wang H, Go VL, et al. Bioavailability and antioxidant activity of tea flavanols after consumption of green tea, black tea, or a green tea extract supplement. Am J Clin Nutr. 2004;80:1558–64.
Henning SM, Wang P, Said JW, Huang M, Grogan T, Elashoff D, Carpenter CL, et al. Randomized clinical trial of brewed green and black tea in men with prostate cancer prior to prostatectomy. Prostate. 2015;75:550–9.
Mulder TP, van Platerink CJ, Wijnand Schuyl PJ, van Amelsvoort JM. Analysis of theaflavins in biological fluids using liquid chromatography-electrospray mass spectrometry. J Chromatogr B Biomed Sci Appl. 2001;760:271–9.
Urpi-Sarda M, Monagas M, Khan N, Lamuela-Raventos RM, Santos-Buelga C, Sacanella E, Castell M, et al. Epicatechin, procyanidins, and phenolic microbial metabolites after cocoa intake in humans and rats. Anal Bioanal Chem. 2009;394:1545–56.
Krupp D, Doberstein N, Shi L, Remer T. Hippuric acid in 24-hour urine is a potential biomarker for fruit and vegetable consumption in healthy children and adolescents. J Nutr. 2012;142:1314–20.
Madrid-Gambin F, Garcia-Aloy M, Vázquez-Fresno R, Vegas-Lozano E, de Villa Jubany MCR, Misawa K, Hase T, et al. Impact of chlorogenic acids from coffee on urine metabolome in healthy human subjects. Food Res Int. 2016;89:1064–70.
Del Rio D, Calani L, Cordero C, Salvatore S, Pellegrini N, Brighenti F. Bioavailability and catabolism of green tea flavan-3-ols in humans. Nutrition. 2010;26:1110–6.
Perez-Jimenez J, Hubert J, Ashton K, Hooper L, Cassidy A, Manach C, Williamson G, et al. Urinary metabolites as biomarkers of polyphenol intake in humans—a systematic review. Am J Clin Nutr. 2010;92:801–9.
Hertog MGL, Hollman PCH, Katan MB, Kromhout D. Intake of potentially anticarcinogenic flavonoids and their determinants in adults in The Netherland. Nutr Cancer. 1993;20:21–9.
Bispo MS, Veloso MC, Pinheiro HL, De Oliveira RF, Reis JO, De Andrade JB. Simultaneous determination of caffeine, theobromine, and theophylline by high-performance liquid chromatography. J Chromatogr Sci. 2002;40:45–8.
Yuan JM, Gao YT, Yang CS, Yu MC. Urinary biomarkers of tea polyphenols and risk of colorectal cancer in the Shanghai Cohort Study. Int J Cancer. 2007;120:1344–50.
Inoue-Choi M, Yuan JM, Yang CS, Van Den Berg DJ, Lee MJ, Gao YT, Yu MC. Genetic association between the COMT genotype and urinary levels of tea polyphenols and their metabolites among daily green tea drinkers. Int J Mol Epidemiol Genet. 2010;1:114–23.
Tulipani S, Llorach R, Jáuregui O, López-Uriarte P, Garcia-Aloy M, Bullo M, Salas-Salvadó J, et al. Metabolomics unveils urinary changes in subjects with metabolic syndrome following 12-week nut consumption. J Proteome Res. 2011;10:5047–58.
Pimpao RC, Ventura MR, Ferreira RB, Williamson G, Santos CN. Phenolic sulfates as new and highly abundant metabolites in human plasma after ingestion of a mixed berry fruit puree. Br J Nutr. 2015;113:454–63.
Brantsaeter AL, Haugen M, Rasmussen SE, Alexander J, Samuelsen SO, Meltzer HM. Urine flavonoids and plasma carotenoids in the validation of fruit, vegetable and tea intake during pregnancy in the Norwegian Mother and Child Cohort Study (MoBa). Public Health Nutr. 2007;10:838–47.
de Vries JH, Hollman PC, Meyboom S, Buysman MN, Zock PL, van Staveren WA, Katan MB. Plasma concentrations and urinary excretion of the antioxidant flavonols quercetin and kaempferol as biomarkers for dietary intake. Am J Clin Nutr. 1998;68:60–5.
Meng X, Lee MJ, Li C, Sheng S, Zhu N, Sang S, Ho CT, et al. Formation and identification of 4′-o-methyl-(−)-epigallocatechin in humans. Drug Metab Dispos. 2001;29:789–93.
Manach C, Williamson G, Morand C, Scalbert A, Remesy C. Bioavailability and bioefficacy of polyphenols in humans. I. Review of 97 bioavailability studies. Am J Clin Nutr. 2005;81:230S–42S.
Landberg R, Aman P, Friberg LE, Vessby B, Adlercreutz H, Kamal-Eldin A. Dose response of whole-grain biomarkers: alkylresorcinols in human plasma and their metabolites in urine in relation to intake. Am J Clin Nutr. 2009;89:290–6.
Linko-Parvinen AM, Landberg R, Tikkanen MJ, Adlercreutz H, Penalvo JL. Alkylresorcinols from whole-grain wheat and rye are transported in human plasma lipoproteins. J Nutr. 2007;137:1137–42.
Bleich SN, Wang YC, Wang Y, Gortmaker SL. Increasing consumption of sugar-sweetened beverages among US adults: 1988–1994 to 1999–2004. Am J Clin Nutr. 2009;89:372–81.
Bremer AA, Auinger P, Byrd RS. Relationship between insulin resistance-associated metabolic parameters and anthropometric measurements with sugar-sweetened beverage intake and physical activity levels in US adolescents: findings from the 1999–2004 National Health and Nutrition Examination Survey. Arch Pediatr Adolesc Med. 2009;163:328–35.
Wang YC, Ludwig DS, Sonneville K, Gortmaker SL. Impact of change in sweetened caloric beverage consumption on energy intake among children and adolescents. Arch Pediatr Adolesc Med. 2009;163:336–43.
Choy K, Nash SH, Kristal AR, Hopkins S, Boyer BB, O'Brien DM. The carbon isotope ratio of alanine in red blood cells is a new candidate biomarker of sugar-sweetened beverage intake. J Nutr. 2013;143:878–84.
Davy BM, Jahren AH, Hedrick VE, Comber DL. Association of delta C-13 in fingerstick blood with added-sugar and sugar-sweetened beverage intake. J Am Diet Assoc. 2011;111:874–8.
Fakhouri TH, Jahren AH, Appel LJ, Chen L, Alavi R, Anderson CA. Serum carbon isotope values change in adults in response to changes in sugar-sweetened beverage intake. J Nutr. 2014;144:902–5.
Nash SH, Kristal AR, Hopkins SE, Boyer BB, O’Brien DM. Stable isotope models of sugar intake using hair, red blood cells, and plasma, but not fasting plasma glucose, predict sugar intake in a Yup’ik study population. J Nutr. 2014;144:75–80.
Schoeller DA. A novel carbon isotope biomarker for dietary sugar. J Nutr. 2013;143:763–5.
Jahren AH, Bostic JN, Davy BM. The potential for a carbon stable isotope biomarker of dietary sugar intake. J Anal At Spectrom. 2014;29:795–816.
Starch_Europe_(European_Starch_Industry_Association) Facts about sugar. http://www.starch.eu/wp-content/uploads/2015/05/Facts-about-sugars-Brochure.pdf. Accessed 13 Jun 2016.
Hedrick VE, Zoellner JM, Jahren AH, Woodford NA, Bostic JN, Davy BM. A dual-carbon-and-nitrogen stable isotope ratio model is not superior to a single-carbon stable isotope ratio model for predicting added sugar intake in Southwest Virginian adults. J Nutr. 2015;145:1362–9.
Nash SH, Kristal AR, Bersamin A, Hopkins SE, Boyer BB, O'Brien DM. Carbon and nitrogen stable isotope ratios predict intake of sweeteners in a Yup’ik study population. J Nutr. 2013;143:161–5.
Tasevska N. Urinary sugars—a biomarker of total sugars intake. Nutrients. 2015;7:5816–33.
Tasevska N, Runswick SA, McTaggart A, Bingham SA. Urinary sucrose and fructose as biomarkers for sugar consumption. Cancer Epidemiol Biomark Prev. 2005;14:1287–94.
Gibbons H, McNulty BA, Nugent AP, Walton J, Flynn A, Gibney MJ, Brennan L. A metabolomics approach to the identification of biomarkers of sugar-sweetened beverage intake. Am J Clin Nutr. 2015;101:471–7.
Lourenco R, Camilo ME. Taurine: a conditionally essential amino acid in humans? An overview in health and disease. Nutr Hosp. 2002;17:262–70.
Crichton G, Alkerwi A, Elias M. Diet soft drink consumption is associated with the metabolic syndrome: a two sample comparison. Nutrients. 2015;7:3569–86.
Souza Bda S, Cunha DB, Pereira RA, Sichieri R. Soft drink consumption, mainly diet ones, is associated with increased blood pressure in adolescents. J Hypertens. 2016;34:221–5.
de Koning L, Malik VS, Rimm EB, Willett WC, Hu FB. Sugar-sweetened and artificially sweetened beverage consumption and risk of type 2 diabetes in men. Am J Clin Nutr. 2011;93:1321–7.
Imamura F, O’Connor L, Ye Z, Mursu J, Hayashino Y, Bhupathiraju SN, Forouhi NG. Consumption of sugar sweetened beverages, artificially sweetened beverages, and fruit juice and incidence of type 2 diabetes: systematic review, meta-analysis, and estimation of population attributable fraction. Br Med J. 2015;351:h3576.
Christiani DC, Chang SH, Chun BC, Lee WJ. Urinary excretion of hippuric acid after consumption of nonalcoholic beverages. Int J Occup Environ Health. 2000;6:238–42.
Choi JW, Ford ES, Gao X, Choi HK. Sugar-sweetened soft drinks, diet soft drinks, and serum uric acid level: the third national health and nutrition examination survey. Arthritis Rheum. 2008;59:109–16.
Bellet S, Kershbaum A, Roman L. Effect of cola drinks on serum free fatty acids. Arch Environ Health. 1968;17:803–6.
Ahmed N, Mirshekar-Syahkal B, Kennish L, Karachalias N, Babaei-Jadidi R, Thornalley PJ. Assay of advanced glycation endproducts in selected beverages and food by liquid chromatography with tandem mass spectrometric detection. Mol Nutr Food Res. 2005;49:691–9.
Bendig P, Maier L, Vetter W. Brominated vegetable oil in soft drinks—an underrated source of human organobromine intake. Food Chem. 2012;133:678–82.
Eisner BH, Asplin JR, Goldfarb DS, Ahmad A, Stoller ML. Citrate, malate and alkali content in commonly consumed diet sodas: implications for nephrolithiasis treatment. J Urol. 2010;183:2419–23.
Logue C, Dowey LC, Strain JJ, Verhagen H, Gallagher AM. The potential application of a biomarker approach for the investigation of low-calorie sweetener exposure. Proc Nutr Soc. 2016;75:216–25.
Christ O, Rupp W. Human experiments with acetosulfam-14C. Pharmacokinetics after oral administration of 30 mg to three healthy male probands. Unpublished report. http://www.inchem.org/documents/jecfa/jecmono/v28je13.htm. Accessed 5 Jun 2015.
Byard JL, McChesney EW, Golberg L, Coulston F. Excretion and metabolism of saccharin in man. II. Studies with 14-C-labelled and unlabelled saccharin. Food Cosmet Toxicol. 1974;12:175–84.
Ball LM, Renwick AG, Williams RT. The fate of [14C]saccharin in man, rat and rabbit and of 2-sulphamoyl[14C]benzoic acid in the rat. Xenobiotica. 1977;7:189–203.
Sweatman TW, Renwick AG, Burgess CD. The pharmacokinetics of saccharin in man. Xenobiotica. 1981;11:531–40.
Wilson LA, Wilkinson K, Crews HM, Davies AM, Dick CS, Dumsday VL. Urinary monitoring of saccharin and acesulfame-K as biomarkers of exposure to these additives. Food Addit Contam. 1999;16:227–38.
Renwick AG, Thompson JP, O'Shaughnessy M, Walter EJ. The metabolism of cyclamate to cyclohexylamine in humans during long-term administration. Toxicol Appl Pharmacol. 2004;196:367–80.
Grice HC, Goldsmith LA. Sucralose—an overview of the toxicity data. Food Chem Toxicol. 2000;38 Suppl 2:S1–6.
Roberts A, Renwick AG, Sims J, Snodin DJ. Sucralose metabolism and pharmacokinetics in man. Food Chem Toxicol. 2000;38 Suppl 2:S31–41.
Bopp BA, Sonders RC, Kesterson JW. Toxicological aspects of cyclamate and cyclohexylamine. CRC Crit Rev Toxicol. 1986;16:213–306.
Geuns JM, Buyse J, Vankeirsbilck A, Temme EH. Metabolism of stevioside by healthy subjects. Exp Biol Med (Maywood). 2007;232:164–73.
Geuns JM, Buyse J, Vankeirsbilck A, Temme EH, Compernolle F, Toppet S. Identification of steviol glucuronide in human urine. J Agric Food Chem. 2006;54:2794–8.
Wheeler A, Boileau AC, Winkler PC, Compton JC, Prakash I, Jiang X, Mandarino DA. Pharmacokinetics of rebaudioside A and stevioside after single oral doses in healthy men. Food Chem Toxicol. 2008;46 Suppl 7:S54–60.
Ubukata K, Nakayama A, Mihara R. Pharmacokinetics and metabolism of N-[N-[3-(3-hydroxy-4-methoxyphenyl) propyl]-alpha-aspartyl]-L-phenylalanine 1-methyl ester, monohydrate (advantame) in the rat, dog, and man. Food Chem Toxicol. 2011;49 Suppl 1:S8–29.
Butchko HH, Stargel WW, Comer CP, Mayhew DA, Benninger C, Blackburn GL, de Sonneville LM, et al. Aspartame: review of safety. Regul Toxicol Pharmacol. 2002;35:S1–93.
Magnuson BA, Burdock GA, Doull J, Kroes RM, Marsh GM, Pariza MW, Spencer PS, et al. Aspartame: a safety evaluation based on current use levels, regulations, and toxicological and epidemiological studies. Crit Rev Toxicol. 2007;37:629–727.
Joint_FAO/WHO_Expert_Committee_on_Food_Additives_(JECFA) Thaumatin. WHO Food Additives Series 20. http://www.inchem.org/documents/jecfa/jecmono/v20je15.htm. Last Accessed 5 Jun 2015.
Borrego F, Montijano H. Neohesperidine dihydrochalcone. In: O'Brien Nabors L, editor. Alternative sweeteners. 3rd ed. New York: Marcel Dekker; 2001. p. 87–105.
U.S. Department of Agriculture, ARS. USDA National Nutrient Database for Standard Reference, Release 28. 2009:Nutrient Data Laboratory Home Page, http://www.ars.usda.gov/nutrientdata. Accessed 5 Jun 2015.
Scalbert A, Rothwell JA, Keski-Rahkonen P, Neveu V. The food metabolome and dietary biomarkers. In: Schoeller DA, Westerterp-Plantenga M, editors. Advances in the Assessment of Dietary Intake. Boca Raton: CRC Press; 2017. p. 259–82.
Allard E, Backstrom D, Danielsson R, Sjobberg JR, Bergquist J. Comparing capillary electrophoresis—mass spectrometry fingerprints of urine samples obtained after intake of coffee, tea, or water. Anal Chem. 2008;80:8946–55.
Hodgson JM, Puddey IB, Croft KD, Burke V, Mori TA, Caccetta RA, Beilin LJ. Acute effects of ingestion of black and green tea on lipoprotein oxidation. Am J Clin Nutr. 2000;71:1103–7.
Mulder TP, Rietveld AG, van Amelsvoort JM. Consumption of both black tea and green tea results in an increase in the excretion of hippuric acid into urine. Am J Clin Nutr. 2005;81:256S–60S.
van der Hooft JJ, de Vos RC, Mihaleva V, Bino RJ, Ridder L, de Roo N, Jacobs DM, et al. Structural elucidation and quantification of phenolic conjugates present in human urine after tea intake. Anal Chem. 2012;84:7263–71.
Rhodes LE, Darby G, Massey KA, Clarke KA, Dew TP, Farrar MD, Bennett S, et al. Oral green tea catechin metabolites are incorporated into human skin and protect against UV radiation-induced cutaneous inflammation in association with reduced production of pro-inflammatory eicosanoid 12-hydroxyeicosatetraenoic acid. Br J Nutr. 2013;110:891–900.
Hodgson JM, Devine A, Puddey IB, Beilby J, Prince RL. Drinking tea is associated with lower plasma total homocysteine in older women. Asia Pac J Clin Nutr. 2006;15:253–8.
Krogholm KS, Bysted A, Brantsaeter AL, Jakobsen J, Rasmussen SE, Kristoffersen L, Toft U. Evaluation of flavonoids and enterolactone in overnight urine as intake biomarkers of fruits, vegetables and beverages in the Inter99 cohort study using the method of triads. Br J Nutr. 2012;108:1904–12.
European_Commission Minutes of the 120th Meeting of the Scientific Committee on Food held on 8–9 March 2000 in Brussels. https://ec.europa.eu/food/sites/food/files/safety/docs/sci-com_scf_out57_en.pdf. Accessed 5 Jan 2017.